Invention Grant
- Patent Title: Dengue virus glycoprotein E DIII variants and uses thereof
-
Application No.: US16064505Application Date: 2017-02-13
-
Publication No.: US10772949B2Publication Date: 2020-09-15
- Inventor: Jonathan R. Lai , Margaret C. Kielian , Julia C. Frei
- Applicant: ALBERT EINSTEIN COLLEGE OF MEDICINE
- Applicant Address: US NY Bronx
- Assignee: Albert Einstein College of Medicine
- Current Assignee: Albert Einstein College of Medicine
- Current Assignee Address: US NY Bronx
- Agency: Foley Hoag LLP
- International Application: PCT/US2017/017637 WO 20170213
- International Announcement: WO2017/142831 WO 20170824
- Main IPC: A61K39/12
- IPC: A61K39/12 ; C07K14/005 ; A61P31/14 ; C12N7/00 ; A61K39/00
Abstract:
Specific Dengue virus glycoprotein subunit E DIII variants and their uses in preventing and treating Dengue virus infection are disclosed.
Public/Granted literature
- US20180360946A1 DENGUE VIRUS GLYCOPROTEIN E DIII VARIANTS AND USES THEREOF Public/Granted day:2018-12-20
Information query
